Displaying 1–25 of 10929 results for
Pfizer has recalled two lots of migraine drug Relpax after finding those lots “may not meet Pfizer’s in-house microbiological specification for the potential presence” of two kinds of bacteria.
The definition of pharma innovation isn’t always clear cut
pharma manufacturing news in review
A federal appeals court affirmed the validity of Sanofi's first patent on prostate-cancer drug, Jevtana, and also overturned a ruling against a later patent on a method of administering it.
An AstraZeneca treatment scored an important victory in the quest to offer new treatments for ovarian cancer.
More details are emerging about the months leading up to Novartis’s admission that data results for its gene therapy Zolgensma were manipulated.
How the use of aseptic split butterfly valve technology can prevent contamination
The drugmaker's Taltz beat out Johnson & Johnson's Tremfya at achieving total skin clearance after 12 weeks of treatment.
The blockbuster eye med is now indicated for an Injection prefilled syringe, which will provide physicians with a new way to administer the treatment with fewer preparation steps.
Pharma Manufacturing's annual Pharma Innovation Award winners offer slices of innovation
Revised GMP guidelines will strengthen emphasis on contamination control, impacting cleanroom performance qualifications
Amgen has fought off a patent challenge from Novartis to its blockbuster anti-inflammatory, Enbrel.
A new study has shown that a pair of experimental treatments could dramatically increase the chances of surviving Ebola.
GlaxoSmithKline announced that Jack Bailey, President U.S. Pharmaceuticals, has decided to step down from his role at the end of the year.
Natco Pharma has received a Form 483 with six observations from the U.S. FDA for the drugmaker's active pharmaceutical ingredient facility located outside Hyderabad, India.
Bayer has acquired BlueRock Therapeutics in a deal valued at $600 million that will give the drugmaker a platform to research and develop new stem cell therapies.
A lead scientist at La Jolla’s Scripps Research has left the biomedical institute
funny pharma cartoon caption contest
The annual Pharma Innovation Awards are our brand's way of acknowledging the investment pharmaceutical equipment vendors put into developing and improving their products.
One of the industry’s leading small-molecule CDMOs is being acquired for $2.4 billion.
Teva Pharmaceuticals announced this week that its chief financial officer is stepping down.
In an attempt to streamline its supply chain of diabetes drugs in the U.S., Novo Nordisk has scooped up a plant from Purdue Pharma.
On May 24, the FDA approved Zolgensma, a gene therapy product intended to treat children less than two years of age with spinal muscular atrophy but was informed recently by the product’s manufacturer about a data manipulation issue that impacts the accuracy of certain data.
The vaccine candidates will be transferred to the Sabin Vaccine Institute in Washington